Recombinant methionyl human leptin therapy in replacement doses improves insulin resistance and metabolic profile in patients with lipoatrophy and metabolic syndrome induced by the highly active antiretroviral therapy (Q40331192)
Jump to navigation
Jump to search
scientific article published on 24 April 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Recombinant methionyl human leptin therapy in replacement doses improves insulin resistance and metabolic profile in patients with lipoatrophy and metabolic syndrome induced by the highly active antiretroviral therapy |
scientific article published on 24 April 2006 |
Statements
1 reference
Recombinant methionyl human leptin therapy in replacement doses improves insulin resistance and metabolic profile in patients with lipoatrophy and metabolic syndrome induced by the highly active antiretroviral therapy (English)
1 reference
Christos S Mantzoros
1 reference
Jennifer H Lee
1 reference
Jean L Chan
1 reference
Epaminondas Sourlas
1 reference
Vassilios Raptopoulos
1 reference
24 April 2006
1 reference
1 reference
Identifiers
1 reference